Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Abbott Laboratories

    NYSE: ABT · Real-Time Price · USD
    133.70
    -3.70 (-2.69%)
    At close: Jun 26, 2025, 3:59 PM
    133.81
    0.08%
    Pre-market: Jun 27, 2025, 08:38 AM EDT

    Abbott Laboratories Statistics

    Share Statistics

    Abbott Laboratories has 1.74B shares outstanding. The number of shares has increased by -0.31% in one year.

    Shares Outstanding

    n/a
    		 1.74B

    Shares Change (YoY)

    n/a
    		 -0.31%

    Shares Change (QoQ)

    n/a
    		 -0.01%

    Owned by Institutions (%)

    n/a
    		 77.56%

    Shares Floating

    n/a
    		 1.73B

    Failed to Deliver (FTD) Shares

    n/a
    		 2,258

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 20.09M, so 1.16% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 20.09M

    Short % of Shares Out

    n/a
    		 1.16%

    Short % of Float

    n/a
    		 1.16%

    Short Ratio (days to cover)

    n/a
    		 2.97

    Valuation Ratios

    The PE ratio is 14.62 and the forward PE ratio is 24.14. Abbott Laboratories's PEG ratio is 0.11.

    PE Ratio

    n/a
    		 14.62

    Forward PE

    n/a
    		 24.14

    PS Ratio

    n/a
    		 4.67

    Forward PS

    n/a
    		 3.9

    PB Ratio

    n/a
    		 4.11

    P/FCF Ratio

    n/a
    		 30.84

    PEG Ratio

    n/a
    		 0.11
    Financial Ratio History

    Enterprise Valuation

    Abbott Laboratories has an Enterprise Value (EV) of 203.28B.

    EV / Sales

    n/a
    		 4.85

    EV / EBITDA

    n/a
    		 18.76

    EV / EBIT

    n/a
    		 23.75

    EV / FCF

    n/a
    		 32.01

    Financial Position

    The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.32.

    Current Ratio

    n/a
    		 1.67

    Quick Ratio

    n/a
    		 1.23

    Debt / Equity

    n/a
    		 0.32

    Debt / EBITDA

    n/a
    		 1.39

    Debt / FCF

    n/a
    		 2.37

    Interest Coverage

    n/a
    		 12.21

    Financial Efficiency

    Return on Equity is 28.12% and Return on Invested Capital is 18.97%.

    Return on Equity

    n/a
    		 28.12%

    Return on Assets

    n/a
    		 16.46%

    Return on Invested Capital

    n/a
    		 18.97%

    Revenue Per Employee

    n/a
    		 $367,982.46

    Profits Per Employee

    n/a
    		 $117,561.4

    Employee Count

    n/a
    		 114,000

    Asset Turnover

    n/a
    		 0.52

    Inventory Turnover

    n/a
    		 3.02

    Taxes

    Income Tax

    n/a
    		 -6.39B

    Effective Tax Rate

    n/a
    		 -91.1%

    Stock Price Statistics

    The stock price has increased by 27.76% in the last 52 weeks. The beta is 0.74, so Abbott Laboratories's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.74

    52-Week Price Change

    n/a
    		 27.76%

    50-Day Moving Average

    n/a
    		 132.61

    200-Day Moving Average

    n/a
    		 123.9

    Relative Strength Index (RSI)

    n/a
    		 49.6

    Average Volume (20 Days)

    n/a
    		 6,768,517

    Income Statement

    In the last 12 months, Abbott Laboratories had revenue of 41.95B and earned 13.4B in profits. Earnings per share was 7.74.

    Revenue

    n/a
    		 41.95B

    Gross Profit

    n/a
    		 23.24B

    Operating Income

    n/a
    		 6.83B

    Net Income

    n/a
    		 13.4B

    EBITDA

    n/a
    		 10.83B

    EBIT

    n/a
    		 7.57B

    Earnings Per Share (EPS)

    n/a
    		 7.74
    Full Income Statement

    Balance Sheet

    The company has 7.62B in cash and 15.02B in debt, giving a net cash position of -7.41B.

    Cash & Cash Equivalents

    n/a
    		 7.62B

    Total Debt

    n/a
    		 15.02B

    Net Cash

    n/a
    		 -7.41B

    Retained Earnings

    n/a
    		 47.26B

    Total Assets

    n/a
    		 81.45B

    Working Capital

    n/a
    		 10.15B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 8.56B and capital expenditures -2.21B, giving a free cash flow of 6.35B.

    Operating Cash Flow

    n/a
    		 8.56B

    Capital Expenditures

    n/a
    		 -2.21B

    Free Cash Flow

    n/a
    		 6.35B

    FCF Per Share

    n/a
    		 3.67
    Full Cash Flow Statement

    Margins

    Gross margin is 55.41%, with operating and profit margins of 16.27% and 31.95%.

    Gross Margin

    n/a
    		 55.41%

    Operating Margin

    n/a
    		 16.27%

    Pretax Margin

    n/a
    		 16.72%

    Profit Margin

    n/a
    		 31.95%

    EBITDA Margin

    n/a
    		 25.83%

    EBIT Margin

    n/a
    		 16.27%

    FCF Margin

    n/a
    		 15.14%

    Dividends & Yields

    ABT pays an annual dividend of $2.87, which amounts to a dividend yield of 1.69%.

    Dividend Per Share

    n/a
    		 $2.87

    Dividend Yield

    n/a
    		 1.69%

    Dividend Growth (YoY)

    n/a
    		 7.27%

    Payout Ratio

    n/a
    		 37.22%

    Earnings Yield

    n/a
    		 6.84%

    FCF Yield

    n/a
    		 3.24%
    Dividend Details

    Analyst Forecast

    The average price target for ABT is $145, which is 8.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $145

    Price Target Difference

    n/a
    		 8.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 16
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $193.5

    Lynch Upside

    n/a
    		 44.73%

    Graham Number

    n/a
    		 69.23

    Graham Upside

    n/a
    		 -48.22%

    Stock Splits

    The last stock split was on Jan 2, 2013. It was a forward split with a ratio of 5000:2399.

    Last Split Date

    n/a
    		 Jan 2, 2013

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 5000:2399

    Scores

    Altman Z-Score

    n/a
    		 6.07

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist